You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 26, 2024

Details for Patent: 8,653,119


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,653,119
Title:Methods for treating transthyretin amyloid diseases
Abstract: Kinetic stabilization of the native state of transthyretin is an effective mechanism for preventing protein misfolding. Because transthyretin misfolding plays an important role in transthyretin amyloid diseases, inhibiting such misfolding can be used as an effective treatment or prophylaxis for such diseases. Treatment methods are disclosed.
Inventor(s): Kelly; Jeffery W. (La Jolla, CA), Powers; Evan T. (La Jolla, CA), Razavi; Hossein (Danbury, CT)
Assignee: The Scripps Research Institute (La Jolla, CA)
Application Number:13/303,060
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 8,653,119

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,653,119

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 1587821 ⤷  Sign Up C300516 Netherlands ⤷  Sign Up
European Patent Office 1587821 ⤷  Sign Up 91935 Luxembourg ⤷  Sign Up
European Patent Office 1587821 ⤷  Sign Up C20120001 00050 Estonia ⤷  Sign Up
European Patent Office 1587821 ⤷  Sign Up CA 2012 00006 Denmark ⤷  Sign Up
European Patent Office 1587821 ⤷  Sign Up 1290005-6 Sweden ⤷  Sign Up
European Patent Office 1587821 ⤷  Sign Up 12C0008 France ⤷  Sign Up
European Patent Office 1587821 ⤷  Sign Up 126 5003-2012 Slovakia ⤷  Sign Up
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.